Company Profiles

driven by the PitchBook Platform

Exicure

Description

Developer of immunomodulatory and gene silencing drugs designed to validate against targets. The company's 3-dimensional spherical nucleic acid (SNA) architecture unlocks the potential of nucleic acid therapeutics in multiple organs, enabling patients suffering from inflammatory disorders to access unparalleled transfection efficiency into numerous cell and tissue types including the skin without carriers or transfection agents.

2009

Founded

PRIVATE

Status

11-50

Employees

Series C

Latest Deal Type

$15M

Latest Deal Amount

$44.6M

Total Amount Raised

Description

Developer of immunomodulatory and gene silencing drugs designed to validate against targets. The company's 3-dimensional spherical nucleic acid (SNA) architecture unlocks the potential of nucleic acid therapeutics in multiple organs, enabling patients suffering from inflammatory disorders to access unparalleled transfection efficiency into numerous cell and tissue types including the skin without carriers or transfection agents.

Website:

www.exicuretx.com

Formerly Known As

AuraSense Therapeutics

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Delivery

Other Industries

Drug Discovery
Other Pharmaceuticals and Biotechnology

Primary Office

8045 Lamon Avenue Suite 410 Skokie, IL 60077United States +1 (847) 673-1700
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Exicure's full profile, request a free trial.

Exicure Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Exicure Investors (13)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
AbbVie VenturesCorporate Venture CapitalMinority000 0000000 0000
Craig MundieAngel (individual)Minority000 0000000 0000
David WaltAngel (individual)Minority000 0000000 0000
Gates VenturesOtherMinority000 0000000 0000
Green MediaOtherMinority000 0000000 0000
AbbVie Ventures Corporate Venture Capital
Craig Mundie Angel (individual)
David Walt Angel (individual)
Gates Ventures Other
Green Media Other

Exicure Executive Team (4)

NameTitleBoard
Seat
Contact
Info
David Giljohann Ph.DCo-Founder, Chief Executive Officer & Board Member
David SnyderChief Financial Officer
Ekambar Kandimalla Ph.DChief Scientific Officer
James TyreeAdvisor
David Giljohann Ph.D Co-Founder, Chief Executive Officer & Board Member
David Snyder Chief Financial Officer
Ekambar Kandimalla Ph.D Chief Scientific Officer
James Tyree Advisor

Exicure Board Members (8)

NameRepresentingRoleSinceContact
Info
Chad Mirkin Ph.DSelfCo-Founder & Chairman000 0000
C. Shad Thaxton Ph.DSelfCo-Founder & Board Member000 0000
David Giljohann Ph.DExicureCo-Founder, Chief Executive Officer & Board Member000 0000
David Walt Ph.DDavid WaltAngel (individual)000 0000
Helen KimSelfBoard Member000 0000
Chad Mirkin Ph.D Co-Founder & Chairman Self
C. Shad Thaxton Ph.D Co-Founder & Board Member Self
David Giljohann Ph.D Co-Founder, Chief Executive Officer & Board Member Exicure
David Walt Ph.D Angel (individual) David Walt
Helen Kim Board Member Self
Request full access to PitchBook